Patent · US Active

Antibodies to EGFL7 and methods for their use

US8398976B2 · kind B2 · utility

2Cited by
1References
57Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 14, 2011
Grant dateMar 19, 2013
Priority date—
Expiry dateApr 14, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/73
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides anti-EGFL7 antibodies, and compositions comprising and methods of using these antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.